Hansoh Pharmaceutical (HKG:3692) will lower the conversion price of its HK$4.68 billion zero-coupon convertible bonds due 2033 to HK$56.54 per share from HK$57.39, effective Sept. 28, according to a Wednesday Hong Kong bourse filing.
The adjustment follows the payment of the interim dividend for the six months ended June 30.
All other terms of the bonds remain unchanged, the filing said.